| Novartis India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.02 | 0.03 | 0.06 | 0.09 | 0.05 |
| Long Term Debt-Equity Ratio | 0.01 | 0.02 | 0.05 | 0.07 | 0.04 |
| Current Ratio | 4.29 | 3.75 | 3.97 | 4.06 | 3.99 |
| Fixed Assets | 14.13 | 11.82 | 7.42 | 4.77 | 8.04 |
| Inventory | 6.73 | 6.78 | 7.62 | 7.15 | 7.35 |
| Debtors | 8.63 | 9.38 | 9.60 | 9.99 | 10.54 |
| Interest Cover Ratio | 83.44 | 66.93 | 9.39 | 6.21 | 5.48 |
| PBIDTM (%) | 37.88 | 32.53 | 13.75 | 15.70 | 10.99 |
| PBITM (%) | 37.11 | 30.93 | 11.34 | 12.51 | 7.99 |
| PBDTM (%) | 37.44 | 32.06 | 12.55 | 13.69 | 9.53 |
| CPM (%) | 26.20 | 28.89 | 12.66 | 8.67 | 5.30 |
| APATM (%) | 25.42 | 27.29 | 10.24 | 5.48 | 2.30 |
| ROCE (%) | 15.57 | 14.88 | 5.66 | 5.57 | 4.24 |
| RONW (%) | 11.21 | 14.09 | 5.84 | 2.92 | 1.36 |